Terms: = Leukemia AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
609 results:
1. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study.
Guo W; Zhao L; Huang W; Chen J; Zhong T; Yan S; Hu W; Zeng F; Peng C; Yan H
Cardiovasc Diabetol; 2024 Apr; 23(1):118. PubMed ID: 38566143
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical analysis of allogeneic hematopoietic stem cell transplantation for seven cases of acute myeloid leukemia with BCR::ABL1 fusion].
Hao MZ; Zhao XL; Zhang XY; Shi YY; Gong M; Zhang LN; Chen SL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):995-1000. PubMed ID: 38503522
[No Abstract] [Full Text] [Related]
3. Investigations of the prognostic value of runx1 mutation in acute myeloid leukemia patients: Data from a real-world study.
Wan CL; Huang YH; Huang SM; Xu YL; Tan KW; Yan-Qiu ; Shen XD; Ge SS; Cao HY; Li YY; Liu SB; Qi JJ; Dai HP; Xue SL
Leuk Res; 2024 Apr; 139():107483. PubMed ID: 38493755
[TBL] [Abstract] [Full Text] [Related]
4. AML with runx1::runx1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
[TBL] [Abstract] [Full Text] [Related]
5. Impact of aml1/ETO Fusion on the Efficacy of Venetoclax Plus Hypomethylating Agents in Newly Diagnosed Acute Myeloid leukemia.
Jin D; Chen H; He J; Li Y; Zheng G; Yang Y; Zhao Y; Le J; Shu W; He D; Cai Z
Target Oncol; 2024 Mar; 19(2):237-249. PubMed ID: 38466536
[TBL] [Abstract] [Full Text] [Related]
6. [The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis].
Zhang WW; Zhang YL; Ren CC; Wu TK; Liu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):176-183. PubMed ID: 38387918
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma].
Jiang YJ; Zhang CF; Wang HX; Zhao L; Zhang FF; Han XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):27-32. PubMed ID: 38387895
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
[No Abstract] [Full Text] [Related]
9. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.
Wang LY; Li Y; Jiang Q; Jiang H; Wang Y; Xu LP; Zhang XH; Liu KY; Tang FF
Hematol Oncol; 2024 Mar; 42(2):e3256. PubMed ID: 38367260
[TBL] [Abstract] [Full Text] [Related]
10. A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia.
Huang T; Leung B; Huang Y; Price L; Gui J; Lau BW
PLoS One; 2024; 19(1):e0292375. PubMed ID: 38289944
[TBL] [Abstract] [Full Text] [Related]
11. Deciphering Acute Myeloid leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells.
Kreissig S; Windisch R; Wichmann C
Cells; 2023 Dec; 13(1):. PubMed ID: 38201282
[TBL] [Abstract] [Full Text] [Related]
12. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
13. [Efficacy and Prognostic Factors of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid leukemia].
Shi YP; Cai B; Yu CL; Qiao JH; Chen XR; Lei YY; Wang Y; Yao B; Li BX; Liu TQ; Ai HS; Guo M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1852-1859. PubMed ID: 38071072
[TBL] [Abstract] [Full Text] [Related]
14. [Safety and the Short-Term Efficacy of Venetoclax Combined with Azacitidine Followed by Cladribine in Children with Refractory/Relapsed Acute Myeloid leukemia].
DU WW; Liu SX; Wang Y; He HL; Guo AL; Hu SY; Lu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1635-1638. PubMed ID: 38071039
[TBL] [Abstract] [Full Text] [Related]
15. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia.
Li Z; Liu X; Wang L; Zhao H; Wang S; Yu G; Wu D; Chu J; Han J
Front Immunol; 2023; 14():1281687. PubMed ID: 38022588
[TBL] [Abstract] [Full Text] [Related]
16. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with runx1::runx1T1.
Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
[TBL] [Abstract] [Full Text] [Related]
17. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with runx1::runx1T1.
Li XP; Dai Y; Zhang WN; Pan MM; Mao J; Zhao B; Jiang L; Gao Y
Int Immunopharmacol; 2023 Dec; 125(Pt B):111178. PubMed ID: 37951201
[TBL] [Abstract] [Full Text] [Related]
18. Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts.
Valent P; Akin C; Arock M; Gleixner KV; Greinix H; Hermine O; Horny HP; Ivanov D; Orfao A; Rabitsch W; Reiter A; Schulenburg A; Sotlar K; Sperr WR; Ustun C
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894806
[TBL] [Abstract] [Full Text] [Related]
19. Acute leukemia with cytogenetically cryptic FGFR1 rearrangement and lineage switch during therapy: A case report and literature review.
McKeague SJ; O'Rourke K; Fanning S; Joy C; Throp D; Adams R; Harvey Y; Keng TB
Am J Clin Pathol; 2024 Feb; 161(2):197-205. PubMed ID: 37855739
[TBL] [Abstract] [Full Text] [Related]
20. runx1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract] [Full Text] [Related]
[Next]
